GI
CVS icon

Glovista Investments’s CVS Health CVS Stock Holding History

Glovista Investments’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,304
Closed -$433K – 86
2020
Q1 		$433K Buy
+7,304
New +$488K 0.22% 62
2019
Q1 		– Sell
-3,551
Closed -$233K – 83
2018
Q4 		$233K Sell
3,551
-3,176
-47% -$237K 0.07% 79
2018
Q3 		$530K Buy
6,727
+776
+13% +$55.5K 0.14% 71
2018
Q2 		$383K Sell
5,951
-99
-2% -$6.52K 0.09% 86
2018
Q1 		$376K Sell
6,050
-100
-2% -$7.17K 0.08% 67
2017
Q4 		$446K Hold
6,150
– – 0.09% 71
2017
Q3 		$500K Buy
6,150
+1
+0% +$79 0.1% 75
2017
Q2 		$495K Buy
6,149
+100
+2% +$7.9K 0.11% 76
2017
Q1 		$475K Buy
6,049
+400
+7% +$31.9K 0.11% 84
2016
Q4 		$446K Sell
5,649
-700
-11% -$56.6K 0.08% 63
2016
Q3 		$565K Buy
6,349
+2,301
+57% +$217K 0.11% 54
2016
Q2 		$388K Buy
4,048
+1,900
+88% +$189K 0.07% 71
2016
Q1 		$223K Buy
+2,148
New +$209K 0.04% 80

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Glovista Investments's CVS Position: Q2 2020 in Review

Glovista Investments sold out of CVS Health (CVS) in Q2 2020, closing a stake of 7,304 shares — an estimated $433K sold.

Glovista Investments first reported a position in CVS in Q1 2016 and held it in 13 quarters. The position peaked at $565K in Q3 2016. 1,863 funds tracked by Wall St. Rank hold CVS as of Q2 2020.

  • Glovista Investments reported no remaining CVS Health position as of Q2 2020 after selling out during the quarter.
  • Glovista Investments sold 7,304 CVS Health shares in Q2 2020, an estimated $433K.
  • Glovista Investments first reported a position in CVS Health in Q1 2016 and held it in 13 quarters.
  • Glovista Investments's CVS Health position peaked at $565K in Q3 2016.
  • 1,863 funds tracked by Wall St. Rank held CVS Health as of Q2 2020.

Based on Glovista Investments's 13F filing for Q2 2020, filed 14 Aug 2020.